KNC Laboratories Co., Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
KNC Laboratories Co., Ltd. owes ¥0.34 for every ¥1 it owns. Net profit rose 4% in the year to Mar 2026, and shrank 21% a year on average over 3 years.
Compared with Basic Materials companies in Japan · latest annual results Mar 2026.
P/E ratio
12.4Investors pay ¥12.4 for every ¥1 of KNC Laboratories Co., Ltd.'s yearly profit, higher than 54% of Basic Materials companies in Japan.
P/B ratio
0.70The share price is 0.70 times KNC Laboratories Co., Ltd.'s book value per share, lower than 62% of Basic Materials companies in Japan.
Market cap
¥9.9 BThe total market value of all of KNC Laboratories Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 76% of Basic Materials companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥14.0 BWhat KNC Laboratories Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥1,810Net worth divided by the number of shares. The share price of ¥1,276 is 0.7 times this, which is the P/B above.
Owes vs Owns
0.34×KNC Laboratories Co., Ltd. owes ¥0.34 for every ¥1 it owns (low), lower than 64% of Basic Materials companies in Japan.
Dividend yield
2.68%KNC Laboratories Co., Ltd. pays 2.68% of its share price as dividends a year, lower than 60% of dividend-paying Basic Materials companies in Japan.
Revenue growth
+11%Revenue rose 11% in the year to Mar 2026, and grew 2% a year on average over 3 years.
Profit growth
+4%Net profit rose 4% in the year to Mar 2026, and shrank 21% a year on average over 3 years.
Profit margin
8.4%KNC Laboratories Co., Ltd. keeps ¥8 of every ¥100 of revenue as net profit.
Cash quality
3.0×Cash from KNC Laboratories Co., Ltd.'s business was 3.0× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
29.7×KNC Laboratories Co., Ltd.'s operating profit covered its interest costs 29.7 times in the year to Mar 2026.
Cash vs debt
Net debtKNC Laboratories Co., Ltd. had ¥1.4 B more debt than cash (net debt) at Mar 2026.
Questions
What is KNC Laboratories Co., Ltd.'s P/E ratio?
Investors pay ¥12.4 for every ¥1 of KNC Laboratories Co., Ltd.'s yearly profit, higher than 54% of Basic Materials companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For KNC Laboratories Co., Ltd.: ¥9.9 B ÷ ¥14.0 B (30 Jun 2026) = 0.7.
How much does KNC Laboratories Co., Ltd. owe compared with what it owns?
KNC Laboratories Co., Ltd. owes ¥0.34 for every ¥1 it owns (low), lower than 64% of Basic Materials companies in Japan.
Does KNC Laboratories Co., Ltd. pay a dividend?
Yes. KNC Laboratories Co., Ltd. pays 2.68% of its share price as dividends a year, lower than 60% of dividend-paying Basic Materials companies in Japan.
Is KNC Laboratories Co., Ltd.'s revenue growing?
Revenue rose 11% in the year to Mar 2026, and grew 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.